KeyBanc raises Zscaler stock price target on improved checks

KeyBanc raised its price target on Zscaler to $190 from $160 while keeping an Overweight rating, citing improved partner performance and stronger quarterly security checks. The firm also highlighted a $122 million, three-year DHS blanket purchase agreement, though it said the contract is unlikely to add to ARR yet. The article presents a mixed backdrop: strong fiscal Q2 2026 results and bullish analyst calls are offset by other downgrades and concerns about competition, platform integration, and channel trends.

Analysis

The market is still treating ZS as a sentiment swing name, but the real signal is that multiple channel checks are converging on the same issue: distribution structure, not just demand, is distorting reads on growth. A move from two-tier to direct sales can mechanically compress partner-reported activity without implying end-market deterioration, which means near-term data may look softer even if bookings quality is improving. That creates a setup where sell-side revisions can stay biased upward while fundamentals inflect later than the stock path.

The bigger second-order effect is competitive: if ZS is winning larger direct deals and more public-sector style agreements, that tends to pressure smaller security vendors that rely on partner-led motion and have less pricing power. The flip side is that the platform-expansion narrative remains fragile; if integration execution slips, the market will quickly re-rate ZS from "category winner" to "good product, unclear consolidation story." For the broader cybersecurity group, this is mildly negative for names whose growth depends on channel enthusiasm, because ZS can absorb wallet share while hiding it inside a cleaner direct pipeline.

The key catalyst window is the next 1-2 quarters, when investors will decide whether recent operating beats are durable or merely a timing benefit from channel reconfiguration. Near-term upside can continue if billings and remaining performance obligations re-accelerate, but the downside tail is that partner data remains noisy and management has to spend to support direct selling and integration priorities. In that scenario, valuation compresses before earnings do, especially if the multiple is already pricing in sustained rule-of-40 expansion.

The contrarian read is that the recent optimism may be underestimating how much of the apparent improvement is mix rather than true demand acceleration. If channel migration is the main issue, then consensus is likely over-weighting survey-based checks and under-weighting direct customer traction and retained expansion. That makes the stock vulnerable to any guide-down in partner commentary, even if reported revenue still looks fine.

Key Decisions for Investors

• Long ZS into the next earnings print, but only via call spreads (2-4 month tenor) to cap downside from channel-noise volatility; target a 1.5-2.0x payoff if direct bookings and ARR stay firm.
• If already long ZS equity, hedge with a near-dated put spread into the next quarterly update; the stock can give back 10-15% quickly if partner checks soften again, even without a fundamental miss.
• Pair trade: long ZS / short a smaller channel-dependent cybersecurity peer basket for 1-3 months; benefit if direct-sales transition is masking share gains at ZS while weaker vendors lose partner support.
• Avoid chasing the move on the back of analyst upgrades alone; wait for confirmation in direct-billed revenue or RPO before adding size, since the next leg is likely driven by execution evidence rather than sentiment.
• Use any 8-10% post-print pop in ZS to trim if the market is rewarding noisy channel improvement more than durable demand, unless management provides clear proof of integration progress and sustained partner health.